×
About 457 results

ALLMedicine™ Prostate-specific Antigen Testing Center

Research & Reviews  197 results

Prostate-specific antigen testing among young men: an opportunity to improve value.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957163
Cancer Medicine; Lange SM, Ambrose JP et. al.

Feb 24th, 2021 - Prostate cancer screening using prostate-specific antigen (PSA) testing remains widespread. The prevalence of PSA testing in young men is unknown and may be an appropriate target for improving health care by decreasing low-value testing in this ag...

Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managin...
https://doi.org/10.1093/clinchem/hvab002
Clinical Chemistry; Ferraro S, Bussetti M et. al.

Feb 23rd, 2021 - Current clinical practice guidelines (CPGs) for early detection of prostate cancer recommend for clinical decision-making a personalized prostate-specific antigen (PSA)-based management to improve the risk-benefit ratio of the screening strategy. ...

Age-adjusted reference values for prostate-specific antigen in a multi-ethnic population.
https://doi.org/10.1111/iju.14519
International Journal of Urology : Official Journal of Th... Matti B, Zargar-Shoshtari K

Feb 18th, 2021 - To establish age-adjusted reference values for prostate-specific antigen in an ethnically diverse population. Between 2009 and 2017, data were collected from all men aged 40-79 years, who had a prostate-specific antigen test in the northern region...

Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805413
The British Journal of General Practice : the Journal of ... Clift AK, Coupland CA et. al.

Jan 12th, 2021 - Prostate cancer is a leading cause of cancer- related death. Interpreting the results from trials of screening with prostate-specific antigen (PSA) is complex in terms of defining optimal prostate cancer screening policy. To assess the rates of, a...

General practitioners' approaches to prostate-specific antigen testing in the north-eas...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747401
BMC Family Practice; Kappen S, Koops L et. al.

Dec 18th, 2020 - There is wide variation in clinical practice for the early detection of prostate cancer, not least because of the ongoing debate about the benefits of prostate-specific antigen (PSA) testing. In this study, we aimed to assess the approaches, attit...

see more →

Guidelines  13 results

Sangia Total PSA Test - P170037
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm630197.htm

Jan 29th, 2019 - The Sangia Total Prostate Specific Antigen (PSA) Test consists of a Cassette Assembly and a Sample Collector. The Sangia Total PSA Test is used as an aid in the diagnosis of prostate cancer. This new test is the first point-of-care test that can d...

Prostate Cancer: Screening
https://screeningforprostatecancer.org/
US Preventive Services Task Force

May 7th, 2018 - For men aged 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA)–based screening for prostate cancer should be an individual one. Before deciding whether to be screened, men should have an opportunity to discuss the po.

Early Detection of Prostate Cancer
http://www.auanet.org/guidelines/early-detection-of-prostate-cancer-(2013-reviewed-and-validity-confirmed-2015)
H. Ballentine Carter

Dec 31st, 2017 - This guideline addresses prostate cancer early detection for the purpose of reducing prostate cancer mortality with the intended user as the urologist. This document does not make a distinction between early detection and screening for prostate ca.

Prostate MRI and MRI-Targeted Biopsy in Patients with Prior Negative Biopsy
http://www.auanet.org/guidelines/prostate-mri-and-mri-targeted-biopsy
Samir S. Taneja

Nov 30th, 2016 - While a large number of template prostate biopsies are performed annually in biopsy-naïve patients in the United States, a majority of the biopsy results are benign1, and a considerable fraction of tumors are missed2. Thus, the subsequent manageme.

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follo...
https://academic.oup.com/annonc/article/26/suppl_5/v69/344382
Parker, C.

Jul 21st, 2015 - Subclinical prostate cancer is common in men >50 years of age. Population-based screening of men aged between 55 and 69 years, using prostate-specific antigen (PSA) testing, has been evaluated in randomised trials [1, 2].

see more →

Drugs  1 results see all →

Clinicaltrials.gov  231 results

Has COVID-19 Led to More Advanced Cancers?
https://www.medscape.com/viewarticle/948278

Mar 28th, 2021 - Months of lockdowns throughout 2020 brought mass cancer screening programs to a halt in the United States. Early in the COVID-19 pandemic, the American Cancer Society recommended that "no one should go to a health care facility for routine cancer ...

Prostate-specific antigen testing among young men: an opportunity to improve value.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957163
Cancer Medicine; Lange SM, Ambrose JP et. al.

Feb 24th, 2021 - Prostate cancer screening using prostate-specific antigen (PSA) testing remains widespread. The prevalence of PSA testing in young men is unknown and may be an appropriate target for improving health care by decreasing low-value testing in this ag...

Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managin...
https://doi.org/10.1093/clinchem/hvab002
Clinical Chemistry; Ferraro S, Bussetti M et. al.

Feb 23rd, 2021 - Current clinical practice guidelines (CPGs) for early detection of prostate cancer recommend for clinical decision-making a personalized prostate-specific antigen (PSA)-based management to improve the risk-benefit ratio of the screening strategy. ...

Age-adjusted reference values for prostate-specific antigen in a multi-ethnic population.
https://doi.org/10.1111/iju.14519
International Journal of Urology : Official Journal of Th... Matti B, Zargar-Shoshtari K

Feb 18th, 2021 - To establish age-adjusted reference values for prostate-specific antigen in an ethnically diverse population. Between 2009 and 2017, data were collected from all men aged 40-79 years, who had a prostate-specific antigen test in the northern region...

Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805413
The British Journal of General Practice : the Journal of ... Clift AK, Coupland CA et. al.

Jan 12th, 2021 - Prostate cancer is a leading cause of cancer- related death. Interpreting the results from trials of screening with prostate-specific antigen (PSA) is complex in terms of defining optimal prostate cancer screening policy. To assess the rates of, a...

see more →

News  15 results

Has COVID-19 Led to More Advanced Cancers?
https://www.medscape.com/viewarticle/948278

Mar 28th, 2021 - Months of lockdowns throughout 2020 brought mass cancer screening programs to a halt in the United States. Early in the COVID-19 pandemic, the American Cancer Society recommended that "no one should go to a health care facility for routine cancer ...

Tailored Messaging Needed to Get Cancer Screening Back on Track
https://www.staging.medscape.com/viewarticle/935799

Aug 16th, 2020 - In late June, Lisa Richardson, MD, emerged from Atlanta, Georgia's initial COVID-19 lockdown, and "got back out there" for some overdue doctor's appointments, including a mammogram. The mammogram was a particular priority for her, since she is dir...

Sangia Total PSA Test - P170037
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm630197.htm

Jan 29th, 2019 - The Sangia Total Prostate Specific Antigen (PSA) Test consists of a Cassette Assembly and a Sample Collector. The Sangia Total PSA Test is used as an aid in the diagnosis of prostate cancer. This new test is the first point-of-care test that can d...

Big Drop in Prostate Cancer Treatment in Recent Years in US
https://www.medscape.com/viewarticle/874586

Jan 17th, 2017 - Treatment rates for prostate cancer have declined significantly since the US Preventive Services Task Force first sounded the alarm about harms from routine use of prostate-specific antigen testing in 2008 (for older men) and again in 2012 (for al...

Prostate Screening Results Anticipated From Urology Meeting
https://www.medscape.com/viewarticle/862694

Apr 28th, 2016 - SAN DIEGO — Significant updates on practice-changing clinical trial results in prostate cancer screening, male sexual dysfunction, and female incontinence will be presented during two late-breaking sessions here at the American Urological Associat...

see more →